Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
Completed · Phase 2
Conditions studied: Hypogonadotropic Hypogonadism
In brief
The goal of this study is to develop novel treatments for patients with a condition called hypogonadotropic hypogonadism (HH) through the use of exogenous kisspeptin.
Key facts
- Study ID
- NCT04648969
- Run by
- Stephanie B. Seminara, MD
- People needed
- 18
- Starts
- 2019-05-03
- Expected to finish
- 2025-08-31
- Last updated by the study team
- 2026-02-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.